GDF15 and cancer: Overall, the combination of the observational data implicating GDF‐15 involvement in cancer cachexia, the preclinical evidence supporting the potential therapeutic relevance of targeting GDF‐15 in amelioration of cancer cachexia and the preliminary phase 1 insights summarized above provided sufficient rationale for this phase 2 PROACC‐1 study (Figure 1).